Penile foreskin is immunologically complete: raises new vaccine possibilities for HIV vaccine

July 23, 2012

Rhesus macaque monkeys infected with simian immunodeficiency virus (SIV) harbor immunoglobulin G (IgG) and SIV-specific antibodies and T cells in the foreskin of the penis, according to a study in the July 2012 Journal of Virology. This is the first time antibody secreting cells, antiviral antibodies or antiviral T cells have been reported in the foreskin of any primate.

Although "it has been known for some time that there was a population of in the surfaces of the human penis, and in all skin, for that matter, the potential functions of these cells, especially with regard to anti-HIV activity, had never been determined," says principal investigator Christopher J. Miller of the University of California, Davis. The new finding, he says, could lead to vaccine strategies designed to elicit HIV-specific immunity in the foreskin.

Cells which are targets of HIV are present in multiple epithelial tissues of the penis, and the foreskin—the skin of the penis that is lost during circumcision—is thought to be an especially important route of HIV transmission. "…the presence of an intact foreskin is associated with an approximately 50 percent increased risk of HIV acquisition," the researchers write, citing seven studies. Although HIV-specific antibodies and are present in semen of HIV-infected humans, very little research has investigated mucosal immune responses of the surface of the penis, says Miller.

Male rhesus macaques are good models for the human reproductive system immunity. "…based on histology, there is no difference in the numbers or locations of CD4+ cells in the inner and outer foreskin of adult [rhesus macaques] or men," according to the report. "In addition to CD4+ T cells, the foreskin and glans of the human penis have a complete population of immune cells, but antigen-specific immune responses in these tissues have not been described [until now]," says Miller.

Miller's lab was also the first to report antiviral T cells in the female genital tract, research which led to efforts to develop vaccines that could elicit anti-HIV immunity in the female reproductive tract.

Explore further: New memory for HIV patients

More information: K. Rothaeusler, Z.-M. Ma, H. Qureshi, T.D. Carroll, T. Rourke, M.B. McChesney, and C.J. Miller, 2012. Antiviral antibodies and T cells are present in the foreskin of simian immunodeficiency virus-infected rhesus macaques. Journal of Virology 86:7098-7106.

Related Stories

New memory for HIV patients

March 26, 2012
The hallmark loss of helper CD4+ T cells during human immunodeficiency virus (HIV) infection may be a red herring for therapeutics, according to a study published on March 26th in the Journal of Experimental Medicine.

Immune cells in the gut may improve control of HIV growth

June 11, 2012
The findings of a new study in monkeys may help clarify why some people infected with HIV are better able to control the virus. They also may pinpoint a target for treatment during early HIV infection aimed at increasing ...

Researchers identify potential new HIV vaccine/therapy target

May 30, 2012
After being infected with simian immunodeficiency virus (SIV) in a laboratory study, rhesus macaques that had more of a certain type of immune cell in their gut than others had much lower levels of the virus in their blood, ...

Recommended for you

Regulatory T cells harbor HIV/SIV virus during antiviral drug treatment

October 17, 2017
Scientists at Yerkes National Primate Research Center, Emory University have identified an additional part of the HIV reservoir, immune cells that survive and harbor the virus despite long-term treatment with antiviral drugs.

New research opens the door to 'functional cure' for HIV

October 17, 2017
In findings that open the door to a completely different approach to curing HIV infections, scientists from the Florida campus of The Scripps Research Institute (TSRI) have for the first time shown that a novel compound effectively ...

Researchers create molecule that could 'kick and kill' HIV

October 5, 2017
Current anti-AIDS drugs are highly effective at making HIV undetectable and allowing people with the virus to live longer, healthier lives. The treatments, a class of medications called antiretroviral therapy, also greatly ...

A sixth of new HIV patients in Europe 50 or older: study

September 27, 2017
People aged 50 and older comprise a growing percentage of HIV patients in Europe, accounting for one in six new cases in 2015, researchers said Wednesday.

Three-in-one antibody protects monkeys from HIV-like virus

September 20, 2017
A three-pronged antibody made in the laboratory protected monkeys from infection with two strains of SHIV, a monkey form of HIV, better than individual natural antibodies from which the engineered antibody is derived, researchers ...

Fighting HIV on multiple fronts might lead to vaccine

September 20, 2017
A combination antibody strategy could be the key to halting the spread of HIV, according to results from two promising animal studies.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.